BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verde F, Tiloca C, Morelli C, Doretti A, Poletti B, Maderna L, Messina S, Gentilini D, Fogh I, Ratti A, Silani V, Ticozzi N. PON1 is a disease modifier gene in amyotrophic lateral sclerosis: association of the Q192R polymorphism with bulbar onset and reduced survival. Neurol Sci 2019;40:1469-73. [PMID: 30903418 DOI: 10.1007/s10072-019-03834-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Su WM, Gu XJ, Duan QQ, Jiang Z, Gao X, Shang HF, Chen YP. Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis. BMC Med 2022;20:209. [PMID: 35754054 DOI: 10.1186/s12916-022-02411-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ravnik-glavač M, Goričar K, Vogrinc D, Koritnik B, Lavrenčič JG, Glavač D, Dolžan V. Genetic Variability of Inflammation and Oxidative Stress Genes Affects Onset, Progression of the Disease and Survival of Patients with Amyotrophic Lateral Sclerosis. Genes 2022;13:757. [DOI: 10.3390/genes13050757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chen GX, Douwes J, van den Berg L, Pearce N, Kromhout H, Glass B, Mclean DJ, 't Mannetje AM. Occupational exposures to pesticides and other chemicals: a New Zealand motor neuron disease case–control study. Occup Environ Med. [DOI: 10.1136/oemed-2021-108056] [Reference Citation Analysis]
4 Vahey J, Gifford EJ, Sims KJ, Chesnut B, Boyle SH, Stafford C, Upchurch J, Stone A, Pyarajan S, Efird JT, Williams CD, Hauser ER. Gene-Toxicant Interactions in Gulf War Illness: Differential Effects of the PON1 Genotype. Brain Sci 2021;11:1558. [PMID: 34942860 DOI: 10.3390/brainsci11121558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Gentile G, Perrone B, Morello G, Simone IL, Andò S, Cavallaro S, Conforti FL. Individual Oligogenic Background in p.D91A-SOD1 Amyotrophic Lateral Sclerosis Patients. Genes (Basel) 2021;12:1843. [PMID: 34946792 DOI: 10.3390/genes12121843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Morrice JR, Shaw CA, Gregory‐evans CY. Susceptibility Genes and Epigenetics in Sporadic ALS. Spectrums of Amyotrophic Lateral Sclerosis 2021. [DOI: 10.1002/9781119745532.ch3] [Reference Citation Analysis]
7 Xu Y, Wang K, Wang Q, Ma Y, Liu X. The Antioxidant Enzyme PON1: A Potential Prognostic Predictor of Acute Ischemic Stroke. Oxid Med Cell Longev 2021;2021:6677111. [PMID: 33628379 DOI: 10.1155/2021/6677111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
8 Reichert CO, Levy D, Bydlowski SP. Paraoxonase Role in Human Neurodegenerative Diseases. Antioxidants (Basel) 2020;10:E11. [PMID: 33374313 DOI: 10.3390/antiox10010011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
9 Tunca C, Şeker T, Akçimen F, Coşkun C, Bayraktar E, Palvadeau R, Zor S, Koçoğlu C, Kartal E, Şen NE, Hamzeiy H, Özoğuz Erimiş A, Norman U, Karakahya O, Olgun G, Akgün T, Durmuş H, Şahin E, Çakar A, Başar Gürsoy E, Babacan Yıldız G, İşak B, Uluç K, Hanağası H, Bilgiç B, Turgut N, Aysal F, Ertaş M, Boz C, Kotan D, İdrisoğlu H, Soysal A, Uzun Adatepe N, Akalın MA, Koç F, Tan E, Oflazer P, Deymeer F, Taştan Ö, Çiçek AE, Kavak E, Parman Y, Başak AN. Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database. Hum Mutat 2020;41:e7-e45. [PMID: 32579787 DOI: 10.1002/humu.24055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Federico A. Rare Neurologic Diseases and Neurological Sciences: a report for the celebration of the 2020 Rare Diseases Day. Neurol Sci 2020;41:491-5. [PMID: 32062737 DOI: 10.1007/s10072-020-04287-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]